Pharmaceutical Excipients Market Size, Share & Industry Analysis, By Type (Organic and Inorganic), By Formulation (OSD, Oral Liquids, Parenteral, Topical & Transdermal, Rectal/Vaginal, and Others), By Functionality (Primary Processing & Performance, Stability & Protection, and Others), By Functionality Application (Stabilizers, Taste Masking, Modified-release, Solubility & Bioavailability Enhancement, and Others), By Source (Plant, Animal, Mineral, Synthetic/Petrochemical, and Others), By End User (Pharma & Biopharma Companies, CMOs/CDMOs, and Others), and Regional Forecast, 2026-2034

Last Updated: April 16, 2026 | Format: PDF | Report ID: FBI115935

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 6.06% from 2026 to 2034
Unit	Value (USD Billion)
Segmentation	By Type, Formulation, Functionality, Functionality Application, Source, End User, and Region
By Type	Organic Chemicals Carbohydrates & Derivatives Polymers Lipids, Fatty Materials & Amphiphiles Surfactants & Solubilizers Proteins, Amino Acids & Other Organics Others Inorganic Chemicals Salts & Buffers Oxides & Hydroxides Silicates, Aluminosilicates & Clays Carbonates & Sulfates Metal-based Specialty Excipients Others
By Formulation	Oral Solid Dosage (OSD) Immediate-release tablets (IR) Modified-release tablets (ER/CR/SR) Capsules (hard gelatin; HPMC) ODT / dispersible tablets Others (OSD) Oral Liquids Solutions/syrups Suspensions Emulsions Oral drops Others Parenteral Small-volume parenterals (SVP) Large-volume parenterals (LVP) Lyophilized injectables Depot/long-acting injectables Others Topical & Transdermal Creams Ointments Gels Lotions Others (Topical & transdermal) Pulmonary & Nasal Dry powder inhalers (DPI) Metered dose inhalers (MDI) Nebulized solutions Nasal sprays Others Ophthalmic & Otic Ophthalmic solutions Ophthalmic suspensions Ophthalmic ointments Ophthalmic gels / in-situ gels Others Rectal / Vaginal Suppositories/pessaries Rectal creams/ointments/gels Vaginal creams/ointments/gels Vaginal tablets Others Others
By Functionality	Primary processing & performance roles Stability & protection roles Patient experience & adherence roles Device-compatibility roles Others
By Functionality Application	Stabilizers Taste masking Modified-release Solubility & bioavailability enhancement Immediate-release & content uniformity enablement Injectability & parenteral compatibility Preservation & microbial control Other functionality applications
By Source	Plant-derived (botanical) Animal-derived Mineral-derived Synthetic / petrochemical-derived Others
By End User	Pharmaceutical & Biopharmaceutical Companies CMOs / CDMOs Research & Academic Institutes Others
By Region	North America (By Type, Formulation, Functionality, Functionality Application, Source, End User, and Country) U.S. Canada Europe (By Type, Formulation, Functionality, Functionality Application, Source, End User, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Type, Formulation, Functionality, Functionality Application, Source, End User, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Type, Formulation, Functionality, Functionality Application, Source, End User, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Type, Formulation, Functionality, Functionality Application, Source, End User, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa